Lung Cancer News

Washington, D.C. - infoZine - Four out of five U.S. adults report having voluntary smoke-free rules in their homes and three out of four report having voluntary smoke-free rules in their vehicles, according to a study published in the journal Preventing Chronic Disease, a publication of the Centers for Disease Control and Prevention.

When it first began, almost all cancer patients didn't survive. Now, two out of three people diagnosed with cancer survive for at least five years, says regional spokeswoman Jill Sittenauer.

The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... There's good news and bad news for Americans.

There's never a shortage of losers in the stock market. Let's take a closer look at five of this past week's biggest sinkers.

Roxarsone, Inorganic Arsenic, and Other Arsenic Species in Chicken: A U.S.-Based Market Basket Sample .

There's one drawback to having the stock market indexes hit record highs yet again: It makes finding truly horrendous health-care stocks for our weekly series much more challenging.

A national survey finds that a large majority of adults in the US voluntarily apply smoke-free rules in their homes or vehicles.

A woman holds a cigarette while walking on campus at The College of New Jersey. A New Jersey state senator wants to ban stores from selling tobacco products to anyone under 21.

On December 19th, 2012, Oncothyreon's shares fell roughly 50% as development partner Merck KGaA reported that L-BLP25 , a cancer immunotherapy that was being tested against non small-cell lung cancer , failed to meet its primary endpoint in a Phase III trial.

It is well known that HPV can lead to deadly cervical cancer in women, but the virus is causing cancer in men as well.

Two drugs from Bristol-Myers Squibb Co. shrank tumors in as many as half of patients with advanced melanoma, according to early research that may pave the way for cocktails that trigger the immune system to destroy cancer.

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Merck KGaA hasn't ruled out pursuing its therapeutic cancer vaccine L-BLP25 after a trial showed the treatment prolonged the lives of a group of advanced lung cancer patients by 50 percent compared with placebo.

Middle-aged men who stayed fit were less likely to die from three common cancers after being diagnosed than those who were out of shape, research found.

Health Canada has issued warnings to the general public and to healthcare professionals that the cancer treatment drug Avastin has been linked to necrotizing fasciitis, an infection commonly known as flesh-eating disease.

Boehringer Ingelheim Ltd. today announced data from Phase III clinical trials involving two different investigational oncology treatments - afatinib* and nintedanib* - in two distinct groups of patients with advanced non-small cell lung cancer .

The U.S. Food and Drug Administration has approved a test designed to detect a faulty gene that's present in about 10 percent of cases of non-small cell lung cancer .

Mother Ethel Ljubic and brother Donovan Ljubic with tattoos of the late Jason Ljubic .

On Sunday, a team of local residents will converge upon Chicago to walk a 5K in honor of a Libertyville resident who is battling stage 4 lung cancer.

The Seattle biotech said in a test of its L-BLP25 drug, conducted by Merck Serono, a division of Merck KGaA of Germany, "the primary endpoint of improving overall survival was not met." But in a subgroup of patients receiving a combination of chemotherapy and radiotherapy , the company reported a median overall survival of 30.8 months for those ... (more)

An experimental drug that taps the power of the body's immune system to fight cancer is shrinking tumors in patients for whom other treatments have failed, an early study shows.